$1.77 EPS Expected for CVS Health Corporation (CVS)

CVS Health Corporation (NYSE:CVS) Logo
Investors sentiment decreased to 1.11 in 2019 Q2. Its down 0.14, from 1.25 in 2019Q1. It dropped, as 90 investors sold CVS Health Corporation shares while 441 reduced holdings. 110 funds opened positions while 481 raised stakes. 948.80 million shares or 2.10% less from 969.19 million shares in 2019Q1 were reported.
Cipher Limited Partnership holds 0.77% or 167,076 shares in its portfolio. 575,401 were reported by Tekla Management Ltd Liability. Deprince Race And Zollo invested in 315,962 shares. Assetmark Incorporated invested 0.07% of its portfolio in CVS Health Corporation (NYSE:CVS). Mcdaniel Terry & has 150,086 shares. Greenwich Wealth Mgmt Limited Com owns 0.22% invested in CVS Health Corporation (NYSE:CVS) for 23,476 shares. Brown Advisory Ltd holds 114,167 shares or 1.66% of its portfolio. Next Fin Gp Incorporated owns 11,425 shares. The New York-based Meyer Handelman Com has invested 0.34% in CVS Health Corporation (NYSE:CVS). Park National Corp Oh invested in 0.37% or 123,955 shares. Moreover, Wallington Asset Mgmt Limited Liability Company has 1.5% invested in CVS Health Corporation (NYSE:CVS). First Mercantile Tru owns 0.07% invested in CVS Health Corporation (NYSE:CVS) for 12,862 shares. Jag Cap Ltd accumulated 5,235 shares. Bristol John W And Company Ny stated it has 0% in CVS Health Corporation (NYSE:CVS). Manufacturers Life Insurance The reported 0.21% in CVS Health Corporation (NYSE:CVS).

Analysts expect CVS Health Corporation (NYSE:CVS) to report $1.77 EPS on November, 5.They anticipate $0.04 EPS change or 2.31 % from last quarter’s $1.73 EPS. CVS’s profit would be $2.31B giving it 8.79 P/E if the $1.77 EPS is correct. After having $1.89 EPS previously, CVS Health Corporation’s analysts see -6.35 % EPS growth. The stock increased 1.67% or $1.02 during the last trading session, reaching $62.24. About 4.70M shares traded. CVS Health Corporation (NYSE:CVS) has declined 17.14% since October 7, 2018 and is downtrending. It has underperformed by 17.14% the S&P500.

CVS Health Corporation (NYSE:CVS) Ratings Coverage

Among 6 analysts covering CVS Health (NYSE:CVS), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. CVS Health has $9100 highest and $58 lowest target. $74’s average target is 18.89% above currents $62.24 stock price. CVS Health had 14 analyst reports since April 11, 2019 according to SRatingsIntel. On Thursday, September 26 the stock rating was maintained by Morgan Stanley with “Overweight”. The rating was maintained by UBS with “Buy” on Thursday, May 2. The rating was maintained by Cowen & Co with “Outperform” on Tuesday, August 27. On Thursday, April 18 the stock rating was maintained by Raymond James with “Strong Buy”. The company was maintained on Monday, April 29 by Morgan Stanley.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. The company has market cap of $81.31 billion. It operates through Pharmacy Services and Retail/LTC divisions. It has a 17.05 P/E ratio. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Prnewswire.com which released: “ROSEN, A LEADING LAW FIRM, Reminds CVS Health Corporation Investors of Important Deadline in Securities Class Action – CVS – PRNewswire” on October 05, 2019, also Businesswire.com with their article: “IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CVS Health Corporation and Encourages Investors with Losses in Excess of $100000 to Contact the Firm – Business Wire” published on September 16, 2019, Fool.com published: “There Will Be Losers As Amazon Makes Another Healthcare Move – The Motley Fool” on September 30, 2019. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Fool.com and their article: “2 Best Cannabis Stocks to Buy in October – The Motley Fool” published on October 06, 2019 as well as Seekingalpha.com‘s news article titled: “Healthy Dividends: CVS-Aetna Synergies Starting To Gain Traction While The Stock Begins To Climb – Seeking Alpha” with publication date: September 08, 2019.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.